openPR Logo
Press release

The US Cardiovascular Needle Market Segmentation Analysis, Key Players, Demands, Trends, Size, Share and Forecasts to 2026

04-18-2022 03:17 PM CET | IT, New Media & Software

Press release from: ReportsnReports

The US cardiovascular needle market was valued at US$21.94 million in 2021, and is foreseen to reach US$31.53 million by 2026. A surgical suture, often known as a stitch or stitches, is a medical device that is used to hold tissues together and wound edges following an injury or surgery. Suturing is a wound-healing method used to close cutaneous wounds. Sutures are used to close skin invisibly, reinforce wounds till they heal, lower the danger of bleeding, and make scars look more appealing.

Get a Free Sample Copy of The US Cardiovascular Needle Market Research Report at https://www.reportsnreports.com/contacts/requestsample.aspx?name=5609446

Surgical needles are required for a variety of cardiovascular treatments, including open-heart surgery, cardiac valve procedures, heart transplant, coronary artery bypass graft surgery, and many others. There are two types of cardiovascular needles: single use or eyeless needles and multiple use or eyed needles. Surgalloy and Ethalloy, two new stainless-steel alloys with high nickel concentrations, are used to make cardiovascular needles. The US cardiovascular needle market is expected to expand at a CAGR of 7.65% during the forecasted period of 2022-2026.

Market Segmentation Analysis:
By Type: The report divides the segments into two different categories on the basis of type: round bodied needles and cutting needles. The round bodied needle segment held the highest share of 57% in 2021, owing to the easy separation of tissues and leak proof suture. The round bodied needle is the most popular type, which is used in all soft tissue approximation including cardiovascular surgery.

By Application: The report has segmented the market into two segments on the basis of application: open heart surgery and cardiac valve procedures. Open heart surgery segment is the fastest growing segment with a CAGR of 8% during the forecast period of 2022-2026, due to the surge in congenital abnormalities and vascular malfunction in the senior population. According to the American Heart Association, at least 48.0% of adults have some form of cardiovascular conditions in the U.S.

Get a 25% Discount on The US Cardiovascular Needle Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=5609446

By Usage: In this report, the market is segmented into two major segments, on the basis of usage: single use and multiple use. Due to the increased awareness of infectious diseases and time efficiency as there is no need to re thread, the single use segment is the fastest growing segment at a CAGR of around 8% during the forecast years of 2022-2026.

By End User: The report includes the bifurcation of market into three segments on the basis of end user: Hospitals and Clinics, Cardiac Centers and Ambulatory Surgical Centers. Hospitals and clinics segment dominated the market in 2021 by occupying more than 60% share. Hospitals are being upgraded with modernized equipment, digital pathology and artificial intelligence as a result of advancements in healthcare facilities. Hospitals collaborate with a variety of doctors, specialists, and other healthcare professionals to provide better care. All cardiovascular disorders requiring the need of cardiovascular needles can be treated in majority of hospitals.

US Cardiovascular Needle Market Dynamics:
Growth Drivers: The US cardiovascular needle market growth is driven by the rising number of cardiovascular procedures in the region. Physical inactivity and an unhealthy lifestyle are increasing the incidence of cardiovascular conditions. Further, the market has been expanding during the past few years, owing to factors such as, rapid urbanization in the US, increasing old age population, increase in the US healthcare expenditure, increased prevalence of diabetes, and advancement in surgeries.

Challenges: Some challenges are also impeding the growth of the market such as the growing use of surgical staples and high costs involved in cardiac treatments. Moreover, the use of robots in cardiovascular surgeries has decreased the demand for needles as robotic procedures require stapling of the wounds.

Trends: In the medical field, technological advancements help to satisfy unmet clinical needs while also opening up new markets. New materials and designs have paved the way for cutting-edge technologies, increasing the potential of the cardiovascular needle market. The further advancements in the technologies and launch of new methods and products like laser drilled cardiovascular needles is expected to improve the efficacy of suturing and drive the market growth in the coming years. Moreover, the integration of AI and telehealth in cardiovascular surgeries is also expected to propel the market growth in the coming years.

Direct Purchase of this Research Report at https://www.reportsnreports.com/purchase.aspx?name=5609446

Impact Analysis of COVID-19 and Way Forward:
The COVID-19 pandemic short-term detrimental impact on the cardiovascular needle market in the US. Because the pandemic has put a strain on healthcare systems all across the world, prioritizing scarce resources was critical to reducing hospital admissions. Cardiac patients not only necessitate ICU resources, but they are also at the highest risk of COVID-19 problems. According to the Society of Thoracic Surgeons Adult Cardiac Surgery Database and Johns Hopkins COVID-19 database, there was a 52.7% reduction in adult cardiac surgery volume and a 65.5% reduction in elective cases in the US.

Consumers are becoming more cognizant of non-reusable products. The increased awareness of infectious and transmissible diseases is expected to drive the growth of single use cardiovascular needle segment during the post COVID period.
Competitive Landscape and Recent Developments:
The US cardiovascular needle market is fragmented. Manufacturers are focusing on using high-quality surgical-grade stainless steel and alloy combinations to create new products that lessen tissue stress. The key players of the market offers a variety of needles with different patterns, shape, size and length. Collaborations and partnerships, innovative product releases, and expansions of manufacturing and distribution units are some of the primary strategies used by companies in the US cardiovascular needle market.

The key players of the US cardiovascular needle market are:
• Johnson & Johnson Inc.
• Medtronic Plc
• Becton, Dickinson and Company (BD),
• Teleflex Incorporated
• Meril Life Science
• KLS Martin Group
• CP Medical
• Sklar Surgical Instruments
• Rumex International Corporation
• FSSB surgical needles GmbH

The key players of the market are also profiled with their operating segments, products offerings and respective business strategies.

Scope of the Report:
The report titled “The US Cardiovascular Needle Market: Analysis By Type, By Application, By Usage, By End User, Size and Trends with Impact of COVID-19 and Forecast up to 2026”, includes :
• An in-depth analysis of the US cardiovascular needle market by type, by application, by usage, by end user, etc.
• Market estimates and forecasts from 2022 to 2026 for effective decision making.
• Provides an analysis of the COVID-19 impact on the US cardiovascular needle market, with post COVID impact analysis.
• Assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the US cardiovascular needle market has also been forecasted for the period 2022-2026, taking into consideration the previous growth patterns, the growth drivers, and the current and future trends.
• Identification of new technological developments, R&D activities, and product launches occurring in the US cardiovascular needle.
• Types of cardiovascular needle offered by top players of the market with description.
• In-depth profiling of the key players, including the assessment of the business overview, market strategies and operating segments of the leading players in the market.
• The recent developments, mergers and acquisitions related to mentioned key players are provided in the market report.
• The in-depth analysis provides an insight into the market, underlining the growth rate and opportunities offered in the business.

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

+ 1 888 391 5441
sales@reportsandreports.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The US Cardiovascular Needle Market Segmentation Analysis, Key Players, Demands, Trends, Size, Share and Forecasts to 2026 here

News-ID: 2605257 • Views:

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presents
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying

All 5 Releases


More Releases for COVID

COVID-19 Diagnostics Market Analysis and Forecast to 2033: COVID-19 and Post-COV …
The COVID-19 diagnostics market is projected to reach a size of US$ 79.41 billion in 2023, with a robust compound annual growth rate (CAGR) of 7.87% from 2023 to 2033. This growth is primarily driven by technological advancements in diagnostic tools and methodologies, enabling faster and more accurate detection of the virus. However, the market faces several challenges, including the perception of high costs, along with concerns regarding test accuracy
COVID-19 Molecular Diagnostics Market Insights by 2027 & Covid-19 Analysis | BD, …
This detailed assessment COVID-19 Molecular Diagnostics market report highlights data about various aspects, which includes growth factors and restraints. Crucial information about market scenario provided in this market report greatly helps key stakeholder in making right decision before making an investment in the market. This report further provides an overview on well-known industries, their market contribution, successful market strategies and latest advancements in present contexts. It also covers market analysis
Europe COVID-19 Diagnostic Market Size | COVID-19 Impact Analysis | Forecast to …
Europe COVID-19 Diagnostic market is estimated to reach $2.6 billion in 2027, by growing at a CAGR of -22.9 % during the forecast period (2021-2027). Several projects for the development of COVID-19, diagnosis, and treatment were reported over the last few months. Additionally, on 22 July 2020, the European Commission declared nearly $117.8 million to co-fund a call for supporting R&D of coronavirus vaccines, and to develop diagnostic tests, treatments,
Anti-Covid nasal spray Market (Covid-19 Impact)| Game Changer For Globe | SaNOti …
Global Anti-Covid nasal spray Market Size, Status and Forecast 2026 Israel and New Zealand have given interim approval for the sale of biotech firm SaNOtize Research and Development’s Nitric Oxide Nasal Spray (NONS) which could help prevent transmission of the COVID-19 virus, the company said on Monday. (Reuters) A self-administered nitric oxide nasal spray (NONS) made by Vancouver-based biotech firm SaNOtize has been found to dramatically reduce Covid-19 viral load in infected
COVID-19 Imparts Positive Impact on Covid-19 Treatment Market | 2020-2027
The Covid-19 treatment market is projected to grow due to increasing cases worldwide requiring short- and long-term respiratory support and multiple partnerships for the development of treatments with clinical trials underway. However, governments all over the world are now responding to the threat of COVID-19 with all the essential measures such as social distancing, nationwide lockdown, travel restrictions, and large-scale quarantines that are anticipated to impact the businesses and consumer
Industrial AI Computers Market 2020 - Pre-COVID-19 and Post-COVID-19 Comparison
Industrial AI Computers Industry 2020 Market Research Report" A new report added by DeepResearchReports.com to its research database. Industrial AI Computers Market is segmented by Regions/Countries. All the key market aspects that influence the Industrial AI Computers market currently and will have an impact on it have been assessed and propounded in the Industrial AI Computers market research status and development trends reviewed in the new report. Download Free PDF Sample